Properties (62)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Kissei_America,_Inc.
|
| gptkbp:advertising |
Focus on niche markets
|
| gptkbp:awards |
Recipient of various industry awards
|
| gptkbp:clinicalTrials |
Conducts clinical trials
Contributes to clinical guidelines Invests in clinical research Conducts Phase I, II, and III trials Works with clinical research organizations |
| gptkbp:collaborations |
Academic institutions
Collaborates with research institutions |
| gptkbp:community_engagement |
Engages with local communities
|
| gptkbp:community_service |
Improves healthcare access
Offers patient support programs Supports healthcare initiatives globally |
| gptkbp:competitors |
Conducts market research
|
| gptkbp:culturalHeritage |
Promotes diversity and inclusion in the workplace
|
| gptkbp:employees |
Approximately 1,000
|
| gptkbp:financialPerformance |
Strong financial performance
|
| gptkbp:founded |
1946
|
| gptkbp:founder |
Kisaburo Kawai
|
| gptkbp:global_presence |
Operates in multiple countries
|
| gptkbp:headquarters |
gptkb:Nagano,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kissei Pharmaceutical
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:innovation |
Focus on innovative drug development
|
| gptkbp:investmentFocus |
Invests heavily in R&D
Invests in technology and innovation |
| gptkbp:keyPeople |
Yoshihiro_Kawai
|
| gptkbp:market |
Global market
|
| gptkbp:partnerships |
Various global pharmaceutical companies
Collaborates with healthcare providers Partnerships with biotech firms |
| gptkbp:patentCitation |
Holds numerous patents
|
| gptkbp:productLine |
Diabetes medications
Cardiovascular medications Oncology medications Urological medications |
| gptkbp:products |
Pharmaceuticals
Focus on unmet medical needs |
| gptkbp:regulatoryCompliance |
Obtains regulatory approvals for drugs
|
| gptkbp:research_areas |
Central nervous system
Respiratory diseases Infectious diseases Metabolic diseases Focus on therapeutic innovation |
| gptkbp:research_focus |
Oncology
Urology Diabetes Cardiovascular diseases |
| gptkbp:revenue |
Approximately $500 million
¥40 billion (2020) |
| gptkbp:social_responsibility |
Engages in corporate social responsibility initiatives
|
| gptkbp:stockExchange |
TSE: 4547
|
| gptkbp:subsidiary |
Kissei_America,_Inc.
|
| gptkbp:sustainability |
Focus on sustainable practices
|
| gptkbp:tactics |
Adopts a global strategy for growth
|
| gptkbp:targetMarket |
Regularly launches new products
|
| gptkbp:tradedOn |
gptkb:Tokyo_Stock_Exchange
|
| gptkbp:training |
Provides employee training programs
|
| gptkbp:type |
Public company
|
| gptkbp:website |
www.kissei.co.jp
|